Your browser doesn't support javascript.
loading
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Healer, Julie; Thompson, Jennifer K; Mackwell, Karen L; Browne, Cecille D; Seager, Benjamin A; Ngo, Anna; Lowes, Kym N; Silk, Sarah E; Pulido, David; King, Lloyd D W; Christen, Jayne M; Noe, Amy R; Kotraiah, Vinayaka; Masendycz, Paul J; Rajagopalan, Rajkannan; Lucas, Leanne; Stanford, Marianne M; Soisson, Lorraine; Diggs, Carter; Miller, Robin; Youll, Susan; Wycherley, Kaye; Draper, Simon J; Cowman, Alan F.
Afiliação
  • Healer J; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Thompson JK; University of Melbourne, Melbourne, VIC, Australia.
  • Mackwell KL; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Browne CD; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Seager BA; Leidos Life Sciences, Frederick, MD, United States.
  • Ngo A; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Lowes KN; University of Melbourne, Melbourne, VIC, Australia.
  • Silk SE; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Pulido D; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • King LDW; University of Melbourne, Melbourne, VIC, Australia.
  • Christen JM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
  • Noe AR; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
  • Kotraiah V; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
  • Masendycz PJ; Leidos Life Sciences, Frederick, MD, United States.
  • Rajagopalan R; Leidos Life Sciences, Frederick, MD, United States.
  • Lucas L; Leidos Life Sciences, Frederick, MD, United States.
  • Stanford MM; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Soisson L; IMV, Inc., Dartmouth, NS, Canada.
  • Diggs C; IMV, Inc., Dartmouth, NS, Canada.
  • Miller R; IMV, Inc., Dartmouth, NS, Canada.
  • Youll S; Malaria Vaccine Development Program, United States Agency for International Development (USAID), Washington, DC, United States.
  • Wycherley K; Malaria Vaccine Development Program, United States Agency for International Development (USAID), Washington, DC, United States.
  • Draper SJ; Malaria Vaccine Development Program, United States Agency for International Development (USAID), Washington, DC, United States.
  • Cowman AF; Malaria Vaccine Development Program, United States Agency for International Development (USAID), Washington, DC, United States.
Front Cell Infect Microbiol ; 12: 1049065, 2022.
Article em En | MEDLINE | ID: mdl-36605129
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas Limite: Animals / Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas Limite: Animals / Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália